CAIRO: Domestically-produced Sovaldi, the sought-after treatment for Hepatitis C, has been meeting demand in markets, and there will be a soon end for patient waiting lists, head of the National Committee for Control of Viral Hepatitis (NCCVH) Waheed Dous told Youm7 Wednesday.
Liver centers are dispensing the medicine to patients regularly, Dous said, adding that the lists are expected to end within three months.
The Health Ministry recently increased outlets distributing the local Sovaldi to 51 venues.
Importing U.S.-made Sovaldi, which has been in full swing since 2014, was recently halted, and replaced with locally-manufactured drugs. The government move hopes to cure some 500,000 patients during 2016 using domestically produced regimens.
NCCVH previously announced that around 157,000 patients have been treated using the Egyptian-made Sovaldi during 2015.
The local version will be available at 900 EGP ($114) instead of 1,200 EGP at privately-owned pharmacies for patients treated at their own expense.
Having one of the highest infection rates of hepatitis C infection in the world, Egypt started in 2014 a treatment regimen based on imported medications that have proved a breakthrough in treating the virus.